$0.77 EPS Expected for MAXIMUS, Inc. (MMS) This Quarter

Analysts expect MAXIMUS, Inc. (NYSE:MMS) to announce $0.77 earnings per share for the current quarter, according to Zacks. Five analysts have issued estimates for MAXIMUS’s earnings, with the highest EPS estimate coming in at $0.79 and the lowest estimate coming in at $0.75. MAXIMUS posted earnings of $0.71 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 8.5%. The company is scheduled to issue its next earnings report before the market opens on Thursday, February 8th.

According to Zacks, analysts expect that MAXIMUS will report full-year earnings of $3.05 per share for the current financial year, with EPS estimates ranging from $3.00 to $3.11. For the next fiscal year, analysts expect that the company will report earnings of $3.33 per share, with EPS estimates ranging from $3.28 to $3.40. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that cover MAXIMUS.

MAXIMUS (NYSE:MMS) last issued its quarterly earnings data on Thursday, November 9th. The health services provider reported $0.81 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.77 by $0.04. MAXIMUS had a net margin of 8.54% and a return on equity of 23.97%. The business had revenue of $620.90 million during the quarter, compared to analyst estimates of $606.86 million.

Several brokerages have commented on MMS. Canaccord Genuity restated a “buy” rating on shares of MAXIMUS in a report on Wednesday, December 27th. Zacks Investment Research lowered shares of MAXIMUS from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the stock. MAXIMUS presently has an average rating of “Hold” and an average price target of $65.60.

Shares of MAXIMUS (MMS) opened at $65.21 on Tuesday. MAXIMUS has a 1-year low of $51.74 and a 1-year high of $72.71. The company has a market cap of $4,420.84, a PE ratio of 20.51, a price-to-earnings-growth ratio of 2.54 and a beta of 1.21.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be given a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, February 14th. MAXIMUS’s dividend payout ratio (DPR) is presently 5.66%.

In other news, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $71.73, for a total transaction of $71,730.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mark Andrekovich sold 2,700 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $72.00, for a total transaction of $194,400.00. Following the sale, the insider now directly owns 20,296 shares of the company’s stock, valued at approximately $1,461,312. The disclosure for this sale can be found here. In the last ninety days, insiders sold 71,417 shares of company stock valued at $4,902,785. 2.48% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Steward Partners Investment Advisory LLC purchased a new stake in MAXIMUS in the 4th quarter worth $169,000. Intl Fcstone Inc. bought a new position in MAXIMUS during the 2nd quarter valued at about $201,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in MAXIMUS by 51.3% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,581 shares of the health services provider’s stock valued at $256,000 after purchasing an additional 1,214 shares during the last quarter. OLD National Bancorp IN bought a new position in MAXIMUS during the 3rd quarter valued at about $246,000. Finally, Cubist Systematic Strategies LLC grew its holdings in MAXIMUS by 16.0% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock valued at $249,000 after purchasing an additional 546 shares during the last quarter. Institutional investors own 96.44% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “$0.77 EPS Expected for MAXIMUS, Inc. (MMS) This Quarter” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/13/0-77-eps-expected-for-maximus-inc-mms-this-quarter.html.


MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Get a free copy of the Zacks research report on MAXIMUS (MMS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply